Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades

Am J Trop Med Hyg. 2014 Jun;90(6):1135-9. doi: 10.4269/ajtmh.14-0013. Epub 2014 Apr 7.

Abstract

Toxoplasma gondii is a ubiquitous parasite that can cause neurologic and ocular disease. We tested sera from 7,072 people ≥ 6 years of age in the 2009-2010 National Health and Nutrition Examination Survey (NHANES) for immunoglobulin G antibodies and compared these results with two previous NHANES studies. The overall T. gondii antibody seroprevalence among persons ≥ 6 years of age in 2009-2010 was 13.2% (95% confidence limit [CL] 11.8%, 14.5%) and age-adjusted seroprevalence was 12.4% (95% CL 11.1%, 13.7%); age-adjusted seroprevalence among women 15-44 years of age was 9.1% (95% CL 7.2%, 11.1%). In U.S. born persons 12-49 years of age, the age-adjusted T. gondii seroprevalence decreased from 14.1% (95% CL 12.7%, 15.5%) in NHANES III (1988-1994) to 9.0% (95% CL 7.6%, 10.5%) in NHANES 1999-2004 to 6.7% (95% CL 5.3%, 8.2%) in NHANES 2009-2010 (P < 0.001 linear trend). Although T. gondii antibody presence is still relatively common, the prevalence in the United States has continued to decline.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Protozoan / blood*
  • Child
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Middle Aged
  • Nutrition Surveys
  • Prevalence
  • Risk Factors
  • Seroepidemiologic Studies
  • Toxoplasma / immunology*
  • Toxoplasma / isolation & purification
  • Toxoplasmosis / epidemiology*
  • Toxoplasmosis / parasitology
  • United States / epidemiology
  • Young Adult

Substances

  • Antibodies, Protozoan
  • Immunoglobulin G